Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Neutral

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Nomura Holdings, Inc (NMR)

https://www.nomuraholdings.com

Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/17/2001

Market Cap

16,914,807,761

Shares Outstanding

3,014,790,000

Weighted SO

3,014,791,393

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

PWP --.--%

OPY --.--%

SF-PC --.--%

PIPR --.--%

SF-PB --.--%

TCJH --.--%

SAI --.--%

SRL --.--%

HLI --.--%

Beta

0.6280

Last Div

0.1000

Range

3.64-6.62

Chg

0.0750

Avg Vol

806116

Mkt Cap

16914807761

Exch

NYSE

Country

JP

Phone

81 3 5255 1000

DCF Diff

1155.0400

DCF

1159.0900

Div Yield

0.0140

P/S

0.8097

EV Multiple

88.9337

P/FV

0.7221

Div Yield %

1.3974

P/E

11.8241

PEG

0.4359

Payout

0.1140

Current Ratio

0.1910

Quick Ratio

0.1910

Cash Ratio

0.1910

DSO

867.9985

DIO

0.0000

Op Cycle

867.9985

DPO

0.0000

CCC

867.9985

Gross Margin

0.0251

Op Margin

0.1064

Pretax Margin

0.1070

Net Margin

0.0685

Eff Tax Rate

0.3259

ROA

0.0035

ROE

0.0632

ROCE

0.0083

NI/EBT

0.6399

EBT/EBIT

1.0059

EBIT/Rev

0.1064

Debt Ratio

0.5595

D/E

9.6514

LT Debt/Cap

0.7926

Total Debt/Cap

0.9061

Int Coverage

0.1602

CF/Debt

0.0177

Equity Multi

17.2515

Rec Turnover

0.4205

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

6.8420

Asset Turnover

0.0517

OCF/Share

200.0563

FCF/Share

158.0334

Cash/Share

1501.8182

OCF/Sales

0.1914

FCF/OCF

0.7899

CF Coverage

0.0177

ST Coverage

0.0293

CapEx Coverage

4.7606

Div&CapEx Cov

3.9864

P/BV

0.7221

P/B

0.7221

P/S

0.8097

P/E

11.8241

P/FCF

5.3550

P/OCF

4.2302

P/CF

4.2302

PEG

0.4359

P/S

0.8097

EV Multiple

88.9337

P/FV

0.7221

DPS

0.0800

Latest Headlines (EST)

GlobeNewswire Inc. May 28, 01:45 Kuehn Law Encourages Investors of Grocery Outlet Holding Corp. to Contact Law Firm GlobeNewswire Inc. May 28, 01:40 Kuehn Law Encourages Investors of Neumora Therapeutics, Inc. to Contact Law Firm GlobeNewswire Inc. Mar 29, 17:05 Class Action Lawsuit Reminder (NMRA): Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. Investors - A Securities Fraud Class Action Lawsuit Has Been Filed GlobeNewswire Inc. Mar 22, 17:28 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – NMRA GlobeNewswire Inc. Mar 18, 22:15 NMRA Lead Plaintiff Deadline Approaching – Contact Robbins LLP for Information About How to Lead the Neumora Therapeutics, Inc. (NMRA) Class Action GlobeNewswire Inc. Mar 14, 00:22 ROSEN, THE FIRST FILING FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – NMRA GlobeNewswire Inc. Mar 09, 20:13 ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – NMRA GlobeNewswire Inc. Mar 07, 00:32 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – NMRA GlobeNewswire Inc. Mar 02, 00:50 Neumora Therapeutics, Inc. (NMRA) Investors: April 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP GlobeNewswire Inc. Feb 25, 00:00 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – NMRA GlobeNewswire Inc. Feb 23, 23:05 NMRA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit GlobeNewswire Inc. Feb 22, 17:38 ROSEN, A RANKED AND LEADING FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – NMRA GlobeNewswire Inc. Feb 19, 23:11 ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – NMRA GlobeNewswire Inc. Feb 18, 01:10 Kessler Topaz Meltzer & Check, LLP - Class Action Announcement for Neumora Therapeutics, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Neumora Therapeutics, Inc. GlobeNewswire Inc. Feb 14, 01:50 ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – NMRA GlobeNewswire Inc. Feb 14, 01:02 Neumora Therapeutics, Inc. Shareholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against NMRA GlobeNewswire Inc. Feb 14, 00:55 NMRA Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Neumora Therapeutics, Inc. GlobeNewswire Inc. Feb 07, 01:30 ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – NMRA GlobeNewswire Inc. Feb 06, 23:25 NMRA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Neumora Class Action Lawsuit Benzinga Jan 02, 23:40 Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - NMRA

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.08 03/27/2024 03/13/2024 11/30/-0001 06/13/2024
0.07 09/29/2021 11/30/-0001 09/30/2021 12/13/2021
0.08 09/26/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.07 06/27/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.16 03/28/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.07 09/27/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.07 06/27/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.31 03/28/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.11 09/27/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.10 03/28/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.09 09/27/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.07 03/26/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.07 09/25/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.12 03/26/2003 11/30/-0001 11/30/-0001 11/30/-0001